Fidelity Growth Company’s FDGRX outstanding leadership continues to be a big advantage, but the fund is vulnerable if chip ...
As China squares off with the U.S. for a second showdown over trade, Xi Jinping is digging in. He's convinced that his top-down approach to managing China's economy, with plans to make it an even ...
Looking ahead to 2025 is a team of Evercore ISI strategists led by Julian Emanuel, who in our call of the day, offer up some stocks which lost ground in 2024 but which could be see a rebound in the ...
Playa Hotels & Resorts NV's stock was rallying 11% in premarket trading on Monday after the company said it agreed to enter into exclusive strategic talks with Hyatt Hotels Corp. in a move that would ...
Netflix and FIFA have agreed to a U.S. broadcast deal for the 2027 and 2031 Women's World Cup, further expanding the streaming company's footprint in the live-sports category, which includes NFL, ...
"I want to start a whole movement," she told Stephen Colbert. "Babygirl" star Nicole Kidman's latest role is causing quite the stir among viewers-but it turns out the actress is also courting ...
Boston Celtics star Jaylen Brown has become the latest athlete to be targeted in a string of robberies that have taken place at the homes of high-profile sports stars, according to multiple reports.
British luxury fashion brand Burberry (UK:BRBY) (BURBY) has rolled out garments and scarves with the letter "B" embroidered with a snake, and has recruited leading Chinese starlet Zhang Jingyi for a ...
Thanks for all the great advice you have given over the years. My situation is a bit of an odd one. My wife and I have been best friends since we were in our teens (we are 45 now). In 2008, before our ...
Two U.S. Navy pilots ejected from their jet fighter over the Red Sea after being caught in "an apparent case of friendly-fire," U.S. Central Command said Sunday, as American forces conducted a new ...
Christine Benz: I wanted to ask about social comparisons, because you’ve got a lot in the book on this topic. You obviously ...
Novo Nordisk's shares recovered some ground on Monday after a 27% slump on Friday in response to an underwhelming set of results from a Phase III trial of its new weight-loss drug CagriSema, but ...